Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |